About US
Contact us
-
OTC Viagra: Pfizer snags nod for nonprescription sales of the little blue pill for men in the U.K.Pfizer has won afirst approval for OTC Viagra. Viagra Connect, the Pfizer OTC name for its blockbuster erectile dysfunction drug, has been approved for sale in the U.K. The Medicine and Healthcare2017/11/29
-
Pfizer, Merck KGaA's Bavencio flops in 'high-risk' stomach cancer trialPfizer and Merck KGaA are working to carve out a niche for immuno-oncology drug Bavencio in a crowded field. But a failed phase 3 trial in advanced stomach cancer just dinged their ambitions. Tuesd2017/11/28
-
Alkermes hit with 3 gender discrimination lawsuits from former staffersAs biopharma grapples with a widespread gender diversity problem, Alkermes faces three lawsuits alleging discriminatory treatment toward female employees, with one suit even claiming it's the company'2017/11/28
-
Novartis looks to poach Advair patients with positive Ultibro switching dataNovartis is looking to snatch patients from GlaxoSmithKline with Advair rival Ultibro Breezhaler. And it has some new data in hand that could help convince doctors and patients to make the switch.2017/11/27
-
As Advair struggles, GlaxoSmithKline seeks expanded label for blockbuster-to-be TrelegyFacing the prospect of generic competition to respiratory superstar Advair—and as the blockbuster's sales falter under pricing pressure—GlaxoSmithKline is pushing to grow new drug Trelegy Ellipta by2017/11/27
-
GlaxoSmithKline taps breath data analyzer to improve COPD patient selectionGlaxoSmithKline is once again getting techy with its clinical trial improvement efforts. The company will incorporate Owlstone Medical’s Breath Biopsy platform, which analyzes biomarkers from breat2017/11/24
-
Acadia launches Parkinson’s campaign to shine light on psychosis symptomsA new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease. Sponsored by Acadia Pharmaceuticals, a TV ad and acc2017/11/24
-
GlaxoSmithKline taps breath data analyzer to improve COPD patient selectionGlaxoSmithKline is once again getting techy with its clinical trial improvement efforts. The company will incorporate Owlstone Medical’s Breath Biopsy platform, which analyzes biomarkers from breat2017/11/23
-
AmerisourceBergen says civil penalty to resolve DOJ probe now at $625MIt turns out that the quarter-crushing $575 million that drug wholesaler AmerisourceBergen set aside to settle civil litigation with the Justice Department was not enough. It is going to take another2017/11/23
-
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefitsLast year, real-world data showed that SGLT2 diabetes drugs could significantly cut heart failure hospitalizations and all-cause deaths. And now, a new analysis shows they can also cut the rate of maj2017/11/22